Intra-Cellular Therapies Investor Relations Material
Latest events
Q3 2024
Intra-Cellular Therapies
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Intra-Cellular Therapies Inc
Access all reports
Intra-Cellular Therapies Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of treatments for central nervous system disorders. The company develops therapies targeting neuropsychiatric and neurological conditions using its proprietary research platform. Its product portfolio includes both marketed treatments and pipeline candidates addressing various mental health and neurological diseases. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
ITCI
Country
🇺🇸 United States